Chronic open-angle glaucoma: case study Understand how to advise on chronic-open angle glaucoma, a condition in which intraocular pressure can permanently damage the optic nerve and nerve fibre, leading to blindness if left untreated.…
Antiviral treatment improves outcomes in patients with advanced cirrhosis Hepatitis C drug shown to reduce the need for transplant and lower mortality rate in patients with advanced liver disease.…
Effects of ADHD drug on the brain are reversible, study suggests Even high doses over an extended treatment period were not detectable in brain regions after a month’s abstinence, according to animal study.…
Leukaemia drug stems allergen response in exploratory study The tyrosine kinase inhibitor ibrutinib can help to block allergic reactions and prevent anaphylaxis, a study finds.…
‘Liquid biopsy’ guides PARP inhibitor treatment of prostate cancer Analysis of circulating free tumour DNA in blood shows how well cancer therapy is working and can inform further treatment.…
Metformin may have cardiovascular benefits in patients with type 1 diabetes Guidelines recommend off-label use of metformin in type 1 diabetes to reduce insulin dosages and improve glycaemic control. However, it is not known whether it has any cardiovascular benefits.…
Experimental cholesterol drug failed to prevent cardiovascular events Phase III trial halted early as treatment did not reduce rate of vascular events in patients with high-risk disease.…
Penicillin allergy often inaccurately recorded by healthcare professionals Researchers find that only one-third of medical records accurately reflected patients’ reported allergic reactions to penicillin.…
Lack of robust post-approval studies under FDA system Review of drugs approved on the basis of limited evidence concludes that stricter rules are needed for post-approval studies.…
Blood sugar self-monitoring in non-insulin treated type 2 diabetes doesn’t improve control It has been debated whether self-monitoring blood glucose levels has any value in improving glycaemic control for patients with type 2 diabetes not requiring insulin.…
